More TAVR News; Cystatin-C for STEMI Prognosis; Transpedal Access - MedPage Today

More TAVR News; Cystatin-C for STEMI Prognosis; Transpedal Access  MedPage Today

Medicare proposed expanding payment for transcatheter aortic valve replacement (TAVR). MedPage Today has more about the requirements here. Direct TAVR ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more